| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/11/2006 | US7026500 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/11/2006 | US7026486 Process for production cilostazol |
| 04/11/2006 | US7026478 Iron catalyzed cross coupling reactions of aromatic compounds |
| 04/11/2006 | US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | US7026310 Heteroaryl derivatives and their use as medicaments |
| 04/11/2006 | CA2245758C Benzo[c]quinolizine derivatives, their preparation and use as 5.alpha.-reductases inhibitors |
| 04/11/2006 | CA2233842C Novel heterocyclic derivatives having indoline, indole or tetrahydroquinoline ring and pharmaceutical use thereof |
| 04/11/2006 | CA2217030C Protease inhibiting succinic acid derivatives |
| 04/06/2006 | US20060074240 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline |
| 04/06/2006 | US20060074238 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074105 Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| 04/06/2006 | US20060074100 Histone deacetylase inhibitors for the treatment of ocular neovascular or edematous disorders and diseases |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1330249B1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | CN1756740A Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| 04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 04/05/2006 | CN1249055C Piperazinylcarbonylquinolines and -isoquinolines |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/04/2006 | US7024068 Electron-driven chirality switches |
| 04/04/2006 | US7022855 Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2179284C Substituted unsymmetrical cyanine dyes with selected permeability |
| 03/30/2006 | WO2006034235A2 Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| 03/30/2006 | WO2006033004A1 Quinoline compounds as cetp inhibitors |
| 03/30/2006 | WO2006033002A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/30/2006 | WO2006033001A1 Quinoline compounds |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/30/2006 | CA2581462A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/29/2006 | EP1640365A1 Metal complex compound and organic electroluminescence device containing the same |
| 03/29/2006 | EP1638928A1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides |
| 03/29/2006 | EP1425270B1 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
| 03/29/2006 | EP1395563B1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | CN1753874A Process for preparing 5-'(r)-2-(5,6-diethyl-indian-2-ylamin o)-1-hydroxy-ethyl-8-hydroxy-(1h)-quinolin-2-one salt, useful as an adrenoceptor agonist |
| 03/29/2006 | CN1247594C Bicyclic heteroaromatic compounds |
| 03/29/2006 | CN1247590C Process for synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f]quinoline |
| 03/29/2006 | CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019143 3-Carboxy,4-oxo-quinoline antibiotics; 7-substituted with-1-piperidine, 1-pyrrolidine or 1-azetidine; multistep synthesis from the 2,4-difluorobenzoic acids; acetylation, amination, cyclization; 7-((3R)-(1S-aminoethyl)-1-pyrrolidinyl)-1-cyclopropyl-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid |
| 03/28/2006 | US7019141 Quinolones with anti-HIV activity |
| 03/28/2006 | US7019139 Quinolinones and uses thereof |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/23/2006 | WO2006031556A2 Amidine substituted aryl aniline compounds |
| 03/23/2006 | WO2006030826A1 Medicinal composition |
| 03/23/2006 | WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 03/23/2006 | WO2005040102A3 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063820 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity |
| 03/23/2006 | CA2580131A1 Substituted aniline derivatives |
| 03/22/2006 | EP1636190A1 Stable crystal of 4-oxoquinoline compound |
| 03/22/2006 | EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 03/22/2006 | EP1107963B1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/22/2006 | CN1751037A Sulfonamide derivatives as PPAR modulators |
| 03/22/2006 | CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
| 03/22/2006 | CN1750825A Flavone acetic acid analogs and methods of use thereof |
| 03/22/2006 | CN1750824A 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/22/2006 | CN1750821A Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/16/2006 | WO2006028270A1 Rebamipide preparation for rectal administration to be prepared before using |
| 03/16/2006 | WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13 |
| 03/16/2006 | WO2006027236A1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 03/16/2006 | US20060058528 Processes for preparing quinolone carboxylate derivatives |
| 03/16/2006 | CA2579059A1 Chemical compounds |
| 03/16/2006 | CA2578789A1 Substituted heterocyclic compounds and uses thereof |
| 03/16/2006 | CA2577861A1 Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 03/15/2006 | EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 03/15/2006 | EP1633732A1 Benzyl sulfonamide derivatives as androgen receptor antagonists |
| 03/15/2006 | EP1633718A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-s |
| 03/15/2006 | EP1633717A1 New p2x7 receptor antagonists and their use |
| 03/15/2006 | EP1633716A2 Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors |
| 03/15/2006 | EP1633694A2 Substituted indoles and a process for preparing substituted indoles |
| 03/15/2006 | EP1633357A1 Polymorphic form of montelukast sodium |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/15/2006 | CN1747934A Crystalline forms of pitavastatin calcium |
| 03/15/2006 | CN1747732A 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 03/14/2006 | US7012145 Method |
| 03/14/2006 | US7012141 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor nad acceptor dyes linked together |
| 03/14/2006 | US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | US7012073 Quinoline derivatives |
| 03/09/2006 | WO2006025480A1 7-substituted carbostyril derivative and method for producing same |
| 03/09/2006 | WO2006024741A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 03/09/2006 | WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052596 preventing or treating cancer or an inflammatory disorder by administering to a subject in need thereof one or more substituted heterocyclic compounds |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052352 Mixtures or organic compounds for the treatment of airway diseases |
| 03/09/2006 | US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 03/09/2006 | CA2572442A1 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |